New Perspectives in Glioblastoma: Nanoparticles-based Approaches
Glioblastoma multiforme represents one of the most aggressive tumor of central nervous system. Current therapy includes surgery, radiation and chemotherapy. These treatments are rarely curative and glioma are associated with a poor prognosis. Nanomedicine represents the most innovative branch of medicine since many studies demonstrated great advantage in the diagnosis and therapy of several diseases. In this review we will summarize the results obtained by the use of nanoparticles and extracellular vesicles in glioblastoma. A great interest is raising from these studies that underlined the efficacy and specificity of this treatment for glioma, reducing side-effects associated with conventional therapies..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Current cancer drug targets - 17(2017), 3, Seite 203-220 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rosa Luciano [VerfasserIn] |
|---|
| Links: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC199357221X |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC199357221X | ||
| 003 | DE-627 | ||
| 005 | 20230513222858.0 | ||
| 007 | tu | ||
| 008 | 170512s2017 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20170501 |
| 035 | |a (DE-627)OLC199357221X | ||
| 035 | |a (DE-599)GBVOLC199357221X | ||
| 035 | |a (PRQ)b1738-7684b8f95fd049768e2b6d0428ccccd411ed200fa518c53579a3ce211e0f20eb0 | ||
| 035 | |a (KEY)0446469920170000017000300203newperspectivesinglioblastomananoparticlesbasedapp | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 100 | 0 | |a Rosa Luciano |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a New Perspectives in Glioblastoma: Nanoparticles-based Approaches |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Glioblastoma multiforme represents one of the most aggressive tumor of central nervous system. Current therapy includes surgery, radiation and chemotherapy. These treatments are rarely curative and glioma are associated with a poor prognosis. Nanomedicine represents the most innovative branch of medicine since many studies demonstrated great advantage in the diagnosis and therapy of several diseases. In this review we will summarize the results obtained by the use of nanoparticles and extracellular vesicles in glioblastoma. A great interest is raising from these studies that underlined the efficacy and specificity of this treatment for glioma, reducing side-effects associated with conventional therapies. | ||
| 700 | 0 | |a Giulia Battafarano |4 oth | |
| 700 | 0 | |a Rossana Saracino |4 oth | |
| 700 | 0 | |a Michela Rossi |4 oth | |
| 700 | 0 | |a Antonio Perrotta |4 oth | |
| 700 | 0 | |a Melania Manco |4 oth | |
| 700 | 0 | |a Maurizio Muraca |4 oth | |
| 700 | 0 | |a Andrea Del Fattore |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current cancer drug targets |d Hilversum [u.a.] : Bentham Science Publ., 2001 |g 17(2017), 3, Seite 203-220 |w (DE-627)338770291 |w (DE-600)2064824-8 |w (DE-576)435515152 |x 1568-0096 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:3 |g pages:203-220 |
| 856 | 4 | 2 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1568-0096&volume=17&issue=3&spage=203 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2017 |e 3 |h 203-220 | ||